It was first evaluated in HER3-expressing tumor cell lines and xenograft models with varying HER3 expressions, demonstrating a specific binding to HER3 and an efficient tumor cell internalization and killing through the release of the cytotoxic payload, leading to DNA damage and, consequently, to tumor cell apoptosis [36]. The gene discussed is ERBB3; the disease is neoplasm.